Moreover, we identified novel AD risk-associated CpG sites and their target genes (CNIH4, THUMPD3, SERPINB9, MTUS1, CISD1, FRAT2, CCDC88B, FES, and SSH2). This evidence concerns the gene FRAT2 and Alzheimer disease.